Safety & PK of Single Doses of MT1980

Clinical trial NCT05429840 · COMPLETED

Trial details

NCT number: NCT05429840
Sponsor: Monument Therapeutics Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroinflammatory Response

Start date: 2022-06-01
Primary completion: 2022-10-04
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.